Corporate Impact Report concluded better patient outcomes and substantial cost savings, thus accelerating Company's sales…
audavantAugust 30, 2023
REDWOOD CITY, Calif., Aug 14, 2023 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”),…
audavantAugust 14, 2023
Company to report robust performance improvements in its operating metrics Record Q1-FY2024 recurring revenue growth…
audavantAugust 11, 2023
Company revolutionizes cardiac preventive care with state-of-the-art AI technology that improves automation, big data analytics…
audavantJuly 25, 2023
REDWOOD CITY, Calif., Jul 21, 2023 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”),…
audavantJuly 21, 2023
Company estimates Q1-FY24 revenue to grow YOY by over 40% Recurring technology fees, customer second-device…
audavantJuly 6, 2023
REDWOOD CITY, Calif., Jun 30, 2023 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”),…
audavantJune 30, 2023
REDWOOD CITY, Calif., Jun 26, 2023 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”),…
audavantJune 26, 2023
REDWOOD CITY, Calif., May 23, 2023 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”),…
audavantMay 23, 2023
